Logo Image
CME
Endorsed By

Alopecia

Breakout Bulletin: July 13-July 17
Logo
Breakout Bulletin: July 13-July 17

Every week, we cut through the noise to bring clinicians the trial results, approvals, and emerging therapies that are actually moving the needle.

Podcasts

View More
Breakout Bulletin: July 13-July 17
Breakout Bulletin: July 13-July 17
The Cutaneous Connection: Representation, Education, and Revolutionizing Sunscreen for Skin of Color
The Cutaneous Connection: Representation, Education, and Revolutionizing Sunscreen for Skin of Color
Single-Dose IL-2 Fusion Protein Shows Hair Regrowth Signal in Early Trial
Single-Dose IL-2 Fusion Protein Shows Hair Regrowth Signal in Early Trial
Semaglutide, Tirzepatide Flag Alopecia Signals in 10-Year FAERS Review
Semaglutide, Tirzepatide Flag Alopecia Signals in 10-Year FAERS Review
New Immune-Mediated Therapies in AD, Alopecia Areata, and HS Presented at SDNP
New Immune-Mediated Therapies in AD, Alopecia Areata, and HS Presented at SDNP
Don't Be Rash: The Sturge-Weber Foundation's 40-Year Case for Early, Coordinated Care
Don't Be Rash: The Sturge-Weber Foundation's 40-Year Case for Early, Coordinated Care
Don't Be Rash: Rethinking Skin Disease in Down Syndrome
Don't Be Rash: Rethinking Skin Disease in Down Syndrome
The Cutaneous Connection: Debunking Allergy Myths and the Future of Atopic Dermatitis Treatment
The Cutaneous Connection: Debunking Allergy Myths and the Future of Atopic Dermatitis Treatment
The Cutaneous Connection: Diving Into the Safety and Efficacy of Icotrokinra, the New Oral IL-23 Peptide in Psoriasis
The Cutaneous Connection: Diving Into the Safety and Efficacy of Icotrokinra, the New Oral IL-23 Peptide in Psoriasis
Don’t Be Rash: Introducing Andrew C. Krakowski, MD, and the Pediatric Dermatology Journey
Don’t Be Rash: Introducing Andrew C. Krakowski, MD, and the Pediatric Dermatology Journey

Continuing Medical Education

View More
Assessing the Evidence for OX40-OX40L Axis Inhibition for the Treatment of Atopic Dermatitis
Video

Assessing the Evidence for OX40-OX40L Axis Inhibition for the Treatment of Atopic Dermatitis

Johann Gudjonsson, MD, PhD; Christopher Bunick, MD, PhD

View more
Navigating Safety Data with Janus Kinase (JAK) Inhibitors in Atopic Dermatitis (AD) Management
Video

Navigating Safety Data with Janus Kinase (JAK) Inhibitors in Atopic Dermatitis (AD) Management

Andrew Alexis, MD, MPH; Leon Kircik, MD

View more
Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient
Video

Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient

Douglas DiRuggiero, DMSc, MHS, PA-C; Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP

View more
Burst CME™: Optimizing Care for Patients with Psoriasis – Incorporating a Buy-and-Bill Model for Biologic Agents into Dermatological Practice
Multimedia

Burst CME™: Optimizing Care for Patients with Psoriasis – Incorporating a Buy-and-Bill Model for Biologic Agents into Dermatological Practice

Jerry Bagel, MD, MS

View more
Patient, Provider, and Caregiver Connection™: Addressing Patient Challenges With Holistic Approaches to Vitiligo Management
Video

Patient, Provider, and Caregiver Connection™: Addressing Patient Challenges With Holistic Approaches to Vitiligo Management

Andrew F. Alexis, MD, MPH; Chesahna Kindred, MD, MBA, FAAD

View more
Hidradenitis Suppurativa: Diving Deeper Into Disease Pathogenesis, Severity Assessment, and Holistic Management Approaches
Video

Hidradenitis Suppurativa: Diving Deeper Into Disease Pathogenesis, Severity Assessment, and Holistic Management Approaches

Hadar Lev-Tov, MD; Martina Porter, MD

View more
Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care
Video

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

View more